[논문] Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study
- 지능형정밀헬스케어융합학과
- 조회수1613
- 2023-02-23
논문명: Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study
저자: 이지연
저널: Lancet Oncol
ISSN: 1470-2045
DOI: 10.1016/S1470-2045(22)00621-0